Literature DB >> 2155115

A kinetic model for 99mTc-DMSA in the rat.

D C Maneval1, D Z D'Argenio, W Wolf.   

Abstract

A pharmacokinetic model was developed for the renal imaging agent 99mTc-DMSA in anesthetized rats, which incorporated data from serial measurements of blood and urine simultaneously with dynamic images obtained over an 8-h period. Animals which received a 10 mg/kg dose of unlabeled DMSA immediately before 99mTc-DMSA injection had a significantly reduced kidney accumulation and greater urinary elimination of 99mTc than animals which received the radiopharmaceutical alone. The kidney clearance was also significantly lower in rats receiving unlabeled DMSA, but no significant difference was determined between the urine clearance estimates of the two animal groups. Because the increase in the amount eliminated in the urine was not coupled with a significant change in urine clearance, it would appear that unlabeled DMSA saturated the kidney uptake mechanism(s) of 99mTc-DMSA without modifying the urinary clearance process. This interpretation is consistent with the hypothesis that renal handling of 99mTc-DMSA is governed by both glomerular filtration and peritubular capillary uptake. The simultaneous acquisition of blood, urine and non invasive image data allows for a comprehensive and informative model of the physiological disposition of 99mTc-DMSA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155115     DOI: 10.1007/BF01566009

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  31 in total

1.  Renal cortical imaging in 35 patients: superior quality with 99mTc-DMSA.

Authors:  D Enlander; P M Weber; L V dos Remedios
Journal:  J Nucl Med       Date:  1974-09       Impact factor: 10.057

2.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

3.  2,3-Dimercaptosuccinic-acid chelates--2. Renal localization.

Authors:  J L Moretti; J R Rapin; J C Saccavini; A Lageron; M Le Poncin; A Bardy
Journal:  Int J Nucl Med Biol       Date:  1984

4.  Optimal handling of dimercaptosuccinic acid for quantitative renal scanning.

Authors:  A Taylor; R L Lallone; P L Hagan
Journal:  J Nucl Med       Date:  1980-12       Impact factor: 10.057

5.  Is the relative 99mTc-DMSA clearance a useful marker of proximal tubular dysfunction?

Authors:  W H van Luijk; G J Ensing; S Meijer; A J Donker; D A Piers
Journal:  Eur J Nucl Med       Date:  1984

6.  The adsorption of 99Tcm dimercaptosuccinic acid onto injection vials.

Authors:  A M Millar
Journal:  Nucl Med Commun       Date:  1984-04       Impact factor: 1.690

7.  Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors.

Authors:  C A Yee; H B Lee; M D Blaufox
Journal:  J Nucl Med       Date:  1981-12       Impact factor: 10.057

8.  Renal handling of technetium-99m DMSA in rats with proximal tubular dysfunction.

Authors:  A P Provoost; M Van Aken
Journal:  J Nucl Med       Date:  1985-09       Impact factor: 10.057

9.  Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1980-12
View more
  3 in total

Review 1.  Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Authors:  S B Charnick; R Kawai; J R Nedelman; M Lemaire; W Niederberger; H Sato
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

2.  A comparative study of evaluating renal scars by 99mTc-DMSA planar and SPECT renal scans, intravenous urography, and ultrasonography.

Authors:  T C Yen; W P Chen; S L Chang; Y C Huang; C P Hsieh; S H Yeh; C Y Lin
Journal:  Ann Nucl Med       Date:  1994-05       Impact factor: 2.668

3.  Decreased renal uptake of (99m)Tc-DMSA in patients with tubular proteinuria.

Authors:  Beom Hee Lee; So Hee Lee; Hyun Jin Choi; Hee Gyung Kang; So Won Oh; Dong Soo Lee; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2009-07-05       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.